These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 2872826)

  • 21. Alprazolam withdrawal delirium unresponsive to diazepam: case report.
    Zipursky RB; Baker RW; Zimmer B
    J Clin Psychiatry; 1985 Aug; 46(8):344-5. PubMed ID: 2862137
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Double-blind clinical assessment of alprazolam, a new benzodiazepine derivative, in the treatment of moderate to severe anxiety.
    Greiss KC; Fogari R
    J Clin Pharmacol; 1980; 20(11):693-9. PubMed ID: 6112245
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Seizures following the withdrawal of alprazolam.
    Noyes R; Perry PJ; Crowe RR; Coryell WH; Clancy J; Yamada T; Gabel J
    J Nerv Ment Dis; 1986 Jan; 174(1):50-2. PubMed ID: 2867122
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The clinical use of clonidine in abrupt withdrawal from methadone. Effects on blood pressure and specific signs and symptoms.
    Charney DS; Sternberg DE; Kleber HD; Heninger GR; Redmond DE
    Arch Gen Psychiatry; 1981 Nov; 38(11):1273-7. PubMed ID: 7305608
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Clonidine in benzodiazepine withdrawal.
    Keshavan MS
    Am J Psychiatry; 1987 Apr; 144(4):530. PubMed ID: 2882698
    [No Abstract]   [Full Text] [Related]  

  • 26. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment.
    Fontaine R; Chouinard G; Annable L
    Am J Psychiatry; 1984 Jul; 141(7):848-52. PubMed ID: 6145363
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Double-blind comparison of alprazolam and diazepam for subchronic withdrawal from alcohol.
    Kolin IS; Linet OI
    J Clin Psychiatry; 1981 Apr; 42(4):169-73. PubMed ID: 7009593
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A case report of alprazolam-induced stuttering.
    Elliott RL; Thomas BJ
    J Clin Psychopharmacol; 1985 Jun; 5(3):159-60. PubMed ID: 2860135
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clonidine decreases opiate withdrawal-related anxiety: possible opiate noradrenergic interaction in anxiety and panic.
    Gold MS; Pottash AL; Sweeney DR; Davies RK; Kleber HD
    Subst Alcohol Actions Misuse; 1980; 1(2):239-46. PubMed ID: 7302782
    [No Abstract]   [Full Text] [Related]  

  • 30. A comparison of buspirone and placebo in relieving benzodiazepine withdrawal symptoms.
    Lader M; Olajide D
    J Clin Psychopharmacol; 1987 Feb; 7(1):11-5. PubMed ID: 2880872
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Use of clonidine in a mixed-drug detoxification regimen: possibility of masking of clinical signs of sedative withdrawal.
    Hughes PL; Morse RM
    Mayo Clin Proc; 1985 Jan; 60(1):47-9. PubMed ID: 2856945
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A controlled trial of ondansetron, a 5-HT3 antagonist, in benzodiazepine discontinuation.
    Romach MK; Kaplan HL; Busto UE; Somer G; Sellers EM
    J Clin Psychopharmacol; 1998 Apr; 18(2):121-31. PubMed ID: 9555597
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The association carbamazepine-mianserin in opiate withdrawal: a double blind pilot study versus clonidine.
    Bertschy G; Bryois C; Bondolfi G; Velardi A; Budry P; Dascal D; Martinet C; Baettig D; Baumann P
    Pharmacol Res; 1997 May; 35(5):451-6. PubMed ID: 9308074
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Noradrenergic hyperactivity in opiate withdrawal supported by clonidine reversal of opiate withdrawal.
    Gold MS; Redmond DE; Kleber HD
    Am J Psychiatry; 1979 Jan; 136(1):100-2. PubMed ID: 364997
    [No Abstract]   [Full Text] [Related]  

  • 35. The role of captodiamine in the withdrawal from long-term benzodiazepine treatment.
    Mercier-Guyon C; Chabannes JP; Saviuc P
    Curr Med Res Opin; 2004 Sep; 20(9):1347-55. PubMed ID: 15383182
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Experiences with clonidine in the therapy of opiate withdrawal].
    Marinelli M; Fresa U; Del Donno M
    Arch Monaldi; 1981; 36(4):203-7. PubMed ID: 6134514
    [No Abstract]   [Full Text] [Related]  

  • 37. A double-blind evaluation of the safety and efficacy of abecarnil, alprazolam, and placebo in outpatients with generalized anxiety disorder. Abecarnil Work Group.
    Lydiard RB; Ballenger JC; Rickels K
    J Clin Psychiatry; 1997; 58 Suppl 11():11-8. PubMed ID: 9363043
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Passionflower in the treatment of opiates withdrawal: a double-blind randomized controlled trial.
    Akhondzadeh S; Kashani L; Mobaseri M; Hosseini SH; Nikzad S; Khani M
    J Clin Pharm Ther; 2001 Oct; 26(5):369-73. PubMed ID: 11679027
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Benzodiazepine use, abuse, and dependence.
    O'brien CP
    J Clin Psychiatry; 2005; 66 Suppl 2():28-33. PubMed ID: 15762817
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multicenter double-blind efficacy and safety study comparing alprazolam, diazepam and placebo in clinically anxious patients.
    Cohn JB
    J Clin Psychiatry; 1981 Sep; 42(9):347-51. PubMed ID: 6115853
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.